Major Plant-Based Compounds for the Prevention and Treatment of Melanoma-A Mini Review

Isabella Kirshteyn1, Megha Srivastav2, Karen Grace2

  • 1College of Medicine, Florida State University, Tallahassee, FL 32304, USA.

Biology
|December 30, 2025
PubMed

Insights

Dietary phytochemicals show promise in preventing and treating malignant melanoma. This review covers their preclinical and clinical relevance over the last decade, focusing on compounds like curcumin and EGCG.

Area of Science:

  • Oncology
  • Nutritional Science
  • Dermatology

Background:

  • Malignant melanoma is a severe cancer with increasing incidence, often linked to UV radiation exposure.
  • Early detection improves melanoma cure rates, but advanced stages are difficult to treat.
  • Naturally occurring dietary agents are being investigated for their potential in cancer chemoprevention and treatment.

Purpose of the Study:

  • To review recent (past decade) preclinical and clinical findings on dietary agents for melanoma prevention and treatment.
  • To examine the cellular pathways modulated by phytochemicals in reducing melanoma tumor burden.
  • To focus on globally consumed phytochemicals like curcumin, sulforaphane, resveratrol, quercetin, and epigallocatechin gallate (EGCG).

Main Methods:

  • Literature review of preclinical studies and clinical trials.
  • Analysis of cellular and molecular mechanisms of phytochemical action.
  • Focus on specific phytochemicals found in common foods.

Main Results:

  • Several phytochemicals demonstrate antitumor and chemopreventive effects against melanoma in preclinical models.
  • Mechanisms include modulation of various cancer-related cellular pathways.
  • Clinical evidence is emerging for some agents, though more research is needed.

Conclusions:

  • Dietary phytochemicals represent a promising avenue for melanoma prevention and adjuvant therapy.
  • Further clinical investigation is warranted to establish efficacy and optimal use.
  • Understanding the mechanisms of action can guide the development of novel therapeutic strategies.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
4.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
926
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K